Related Experiment Video
Updated: Jul 1, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Stereotactic radiosurgery for a cardiac sarcoma: a case report.
Scott G Soltys1, M Yashar S Kalani, Samuel H Cheshier
1Department of Radiation Oncology, Stanford University Medical Center. sgsoltys@stanford.edu
Technology in Cancer Research & Treatment
|September 12, 2008
Summary
This case study shows CyberKnife stereotactic radiosurgery can safely treat recurrent pulmonary artery sarcoma, offering clinical and radiographic improvement. The treatment demonstrated feasibility and short-term safety in a palliative setting for this rare cancer.
Area of Science:
- Oncology
- Radiation Oncology
- Cardiovascular Surgery
Background:
- Pulmonary artery intimal sarcoma is a rare and aggressive malignancy.
- Recurrence after surgical resection carries a poor prognosis.
- Palliative treatment options for recurrent disease are limited.
Observation:
- A 75-year-old male presented with recurrent pulmonary artery sarcoma post-surgery.
- CyberKnife stereotactic radiosurgery was employed for symptom palliation.
- The patient experienced clinical and radiographic response to the treatment.
Findings:
- CyberKnife radiosurgery demonstrated feasibility and short-term safety.
- No acute or sub-acute toxicity was observed during the treatment period.
- The patient's death occurred 10 weeks post-treatment due to metastatic disease.
Implications:
- Stereotactic radiosurgery may be a viable palliative option for recurrent pulmonary artery sarcoma.
- Careful stereotactic planning is crucial, considering mediastinal organ movement and radiation tolerance.
- Further research is warranted to evaluate long-term efficacy and safety of this technique.
